TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases. It products include Birinapant, and SHAPE. The company was founded by John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.
